Alpha Cubed Investments’s AstraZeneca AZN Stock Holding History

Alpha Cubed Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18,862	Closed	-$1.2M	–	179
2015 Q3	$1.2M	Sell	18,862 -15,585	-45%	-$1.03M	0.32%	69
2015 Q2	$2.19M	Sell	34,447 -17,260	-33%	-$1.18M	0.59%	51
2015 Q1	$3.54M	Sell	51,707 -944	-2%	-$65.6K	1.1%	29
2014 Q4	$3.71M	Sell	52,651 -7,084	-12%	-$507K	1.45%	22
2014 Q3	$4.27M	Buy	+59,735	New	+$4.37M	2.01%	8

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Alpha Cubed Investments's AZN Position: Q4 2015 in Review

Alpha Cubed Investments sold out of AstraZeneca (AZN) in Q4 2015, closing a stake of 18,862 shares — an estimated $1.2M sold.

Alpha Cubed Investments first reported a position in AZN in Q3 2014 and held it in 5 quarters. The position peaked at $4.27M in Q3 2014. 390 funds tracked by Wall St. Rank hold AZN as of Q4 2015.

Alpha Cubed Investments reported no remaining AstraZeneca position as of Q4 2015 after selling out during the quarter.
Alpha Cubed Investments sold 18,862 AstraZeneca shares in Q4 2015, an estimated $1.2M.
Alpha Cubed Investments first reported a position in AstraZeneca in Q3 2014 and held it in 5 quarters.
Alpha Cubed Investments's AstraZeneca position peaked at $4.27M in Q3 2014.
390 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2015.

Based on Alpha Cubed Investments's 13F filing for Q4 2015, filed 8 Feb 2016.